scorecardresearch
Add as a preferred source on Google
Tuesday, November 25, 2025
TopicRemdesivir

Topic: Remdesivir

Remdesivir trial discovers a Covid weak spot and why this success is critical

In episode 458 of #CutTheClutter, Shekhar Gupta explains the significance of the randomised trial of remdesivir's effectiveness on treating Covid-19.

This is how remdesivir, developed for Hepatitis C and Ebola, fights Covid-19

The experimental antiviral drug that was developed by US pharmaceutical company Gilead Sciences has shown that it leads to faster recovery in Covid-19 patients.

Remdesivir has clear-cut, positive effect on cutting Covid recovery time, says top US doctor

The claims of Dr Anthony Fauci come at the time a study in The Lancet has said ‘remdesivir is not associated with statistically significant clinical benefits’.

Why some experts want more data before they are convinced about remdesivir

Some experts say science has taken a back seat to optimism in the rush to find a way out of the coronavirus crisis that has paralysed economies around the world.

Remdesivir trial shows Covid-19 patients recover faster, could be first effective drug

The US trial looked at whether Gilead’s remdesivir helped people with Covid-19 recover faster than without it.

On Camera

Worker exploitation powers the firework industry in Tamil Nadu’s Sivakasi

For an industry globally classified as hazardous, protections such as health insurance and a provident fund for workers are necessities. In Sivakasi, they remain elusive.

172 countries & counting, India looks to hit new record in rice exports. But there’s a flip side

The industry forecasts exports are set to grow 16% in 2025-26, boosted by surplus domestic production and a drive to push into 26 underserved global markets with strong potential.

India and France to jointly manufacture HAMMER air-to-surface missile

Indigenisation level will progressively increase up to 60 percent with key sub-assemblies, electronics and mechanical parts being manufactured locally.

A tribute to Tejas. India’s delay culture is the real enemy in the skies

It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.